However, it has been shown that there was no correlation between TS expression in NSCLC tissues and the development of pemetrexed resistance in patients [12], suggesting that the mechanism of pemetrexed resistance is not fully understood. This evidence concerns the gene TYMS and non-small cell lung carcinoma.